Changes in serum carbonyl and malondialdehyde levels following colchicine and Vitamin E treatment in Behçet's disease

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 29, Issue 8, 2007, Pages 521-524

  Gülbahar, Özlem ^a,d   Adisen H ^b   Koca, C ^c   Aricioglu A ^a   Gulekon A ^b  

^a Department of Medical Biochemistry ^*  (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c FATIH UNIVERSITY   (Turkey)

^d GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Beh et's disease; Carbonyl level; Colchicine; Malondialdehyde; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CARBONYL DERIVATIVE; COLCHICINE; MALONALDEHYDE;

ARTICLE; BEHCET DISEASE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; LIPID OXIDATION; LIPID PEROXIDATION; MALE; MONOTHERAPY;

ANTIOXIDANTS; BEHCET SYNDROME; COLCHICINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PROSPECTIVE STUDIES; PROTEIN CARBONYLATION; REACTIVE OXYGEN SPECIES; VITAMIN E;

EID: 37149019532     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2007.29.8.1118136     Document Type: Article

References (28)

1. Bang, D. Clinical spectrum of Behçet's disease. J Dermatol 2001, 28: 610-3.
2. Michelson, J.B., Friedlaender, M.H. Behçet's disease. Int Ophthal Clin 1990, 30: 271-8.
3. Örem, A., Efe, H., Deǧer, O., Çimşit, G., Uydu, A.H., Vanizor, B. Relationship between lipid peroxidation and disease activity in patients with Behçet's disease. J Dermatol Sci 1997, 16: 11-6.
4. Chambers, J.C., Haskard, D.O., Kooner, J.S. Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol 2001, 37: 517-20.
5. Weiss, S.J. Tissue destruction by neutrophils. N Eng J Med 1989, 320: 365-76.
6. Jorizzo, J.L., Hudson, R.D., Schmalstieg, F.C. Behçet's syndrome: Immune regulation, circulating immune complexes, neutrophil migration, and colchicine therapy. J Am Acad Dermatol 1984, 10: 205-14.
7. Köse, K., Yazici, C., Çambay, N., Aşçioǧ lu, Ö., Doǧan, P. Lipid peroxidation and erythrocyte antioxidant enzymes in patients with Behçet's disease. Tohoku J Exp Med 2002, 197: 9-16.
8. Niwa, Y., Miyake, S., Sakane, T., Shingu, M., Yokoyama, M. Auto-oxidative damage in Behçet's disease: Endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 1982, 49: 247-55.
9. Stadtman, E.R., Levine, R.L. Protein oxidation. Ann NY Acad Sci USA 2000, 899: 191-208.
10. Ghate, J.V., Jorizzo, J.L. Behçet's disease and complex aphthosis. J Am Acad Dermatol 1999, 40: 1-12.
11. Hijikata, K., Masuda, K. Visual prognosis in Behçet's disease: Effects of cyclosphamide and colchicine. Jpn J Ophtalmol 1978, 22: 506-19.
12. Matsumura, N., Mizushima, Y. Leucocyte movement and colchicine treatment in Behçet's disease. Lancet 1975, 2: 813.
13. Aktulga, E., Altac, M., Muftu, A. A double blind study of colchicine in Behçet's disease. Haematologica 1980, 65: 399-402.
14. Kökçam, İ., Naziroǧlu, M. Effects of vitamin E supplementation on blood antioxidants levels in patients with Behçet's disease. Clin Biochem 2002, 35: 633-9.
15. Sangha, O., Stucki, G. Vitamin E therapy of rheumatic diseases. Z Rheumatol 1998, 57: 207-14.
16. International Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 1990, 335: 1078-80.
17. Levine, R.L., Garland, D., Oliver, C.N. et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990, 186: 464-78.
18. Yoshioka, T., Kawada, K., Shimada, T., Mori, M. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am J Obstet Gynecol 1979, 135: 372-6.
19. Brownlee, M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1995, 46: 223-34.
20. Raj, D.S., Choudhury, D., Welbourne, T.C., Levi, M. Advanced glycation end products: A nephrologist's perspective. Am J Kidney Dis 2000, 35: 365-80.
21. Garibaldi, S., Aragno, I., Odetti, P., Marinari, U.M. Relationships between protein carbonyls, retinol, and tocopherols level in human plasma. Biochem Mol Biol Int 1994, 34: 729-36.
22. Bekpinar, S., Kiliç, N., Ünlüçerçi, Y., Akdag-Köse, A., Azizlerli, G., Özbek-Kir, Z. Evaluation of nitrosative and oxidative stress in Behçet disease. JEADV 2005, 19: 167-71.
23. Yazici, C., Köse, K., Çaliş, M., Demir, M., Kirnap, M., Ateş, F. Increased advanced oxidation protein products in Behçet's disease: A new activity marker? Br J Dermatol 2004, 151: 105.
24. Köse, K., Doǧan, P., Aşçioǧlu, M., Erkiliç, K., Aşçioǧlu, O. Oxidative stress and antioxidant defenses in plasma of patients with Behçet's disease. Tohoku J Exp Med 1951, 76: 239-48.
25. Köse, K., Yazici, C., Aşçioǧlu, O. The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behçet's disease. Clin Biochem 2001, 34: 125-9.
26. Freitas, J.P., Filipe, P., Yousefi, A., Emerit, I., Guerra, R.F. Oxidative stress in Adamantiades-Behçet's disease. Dermatology 1998, 197: 343-8.
27. Fariss, M.W., Zhang, J. Vitamin E therapy in Parkinson' disease. Toxicology 2003, 189: 129-49.
28. Saglam, K., Serce, A.F., Yilmaz, M.I. Trace elements and antioxidant enzymes in Behcet's disease. Rheumatol Int 2002, 22: 93-96.